GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3326 - 3350 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 1 10 moderate
G68703KI
45
IgG Patient 1 22 moderate
G09482NW
45
IgG Patient 1 22 moderate
G65889KE
45
IgG Patient 1 6 moderate
G21290RB
45
IgM Patient 1 10 moderate
G00048MO
45
IgM Patient 1 10 moderate
G32473MI
45
IgM Patient 1 10 moderate
G38488WF
45
IgM Patient 1 22 moderate
G00048MO
45
IgM Patient 1 22 moderate
G82096UQ
45
IgM Patient 1 6 moderate
G07483YN
45
IgM Patient 1 6 moderate
G08520NM
45
IgM Patient 1 6 moderate
G93351GM
45
IgG Patient 2 15 mild
G03499BP
45
IgG Patient 2 15 mild
G58969RU
45
IgG Patient 2 24 mild
G16579HJ
45
IgG Patient 2 24 mild
G66937TJ
45
IgM Patient 2 15 mild
G00054MO
45
IgM Patient 2 24 mild
G00065MO
45
IgM Patient 2 24 mild
G76615YG
45
IgG Patient 2 3 mild
G39023AU
45
IgM Patient 2 3 mild
G02557XE
45
IgM Patient 2 3 mild
G96881BQ
45
IgG Patient 3 -180 mild
G10789DJ
45
IgG Patient 3 -180 mild
G58547FH
45
IgG Patient 3 -180 mild
G86541PE
45

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024